- Home
- KLRA vs NFJ Comparison
KLRA vs NFJ Comparison
Compare KLRA & NFJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KLRA | NFJ |
|---|---|---|
| Founded | 2024 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | 2026 | 2003 |
Fundamental Metrics
Financial Performance| Metric | KLRA | NFJ |
|---|---|---|
| Price | $12.75 | $14.56 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $42.40 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 348.9K |
| Earning Date | 11-23-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.01% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.76 | $12.25 |
| 52 Week High | $23.82 | $15.75 |
Technical Indicators
Market Signals| Indicator | KLRA | NFJ |
|---|---|---|
| Relative Strength Index (RSI) | 52.61 | 39.94 |
| Support Level | $9.76 | $14.50 |
| Resistance Level | $19.15 | $15.24 |
| Average True Range (ATR) | 0.86 | 0.28 |
| MACD | 0.44 | 0.01 |
| Stochastic Oscillator | 82.09 | 39.62 |
Price Performance
Historical ComparisonAbout KLRA Kailera Therapeutics Inc. Common Stock
Kailera Therapeutics Inc is a clinical-stage biotechnology company. The company focuses on developing a diversified pipeline to provide options for people living with obesity. The company is progressing four clinical-stage product candidates, leveraging multiple GLP-1 based mechanisms of action and routes of administration. The company's obesity-first approach seeks to advance product candidates with the potential to maximize weight loss and address critical needs in the current therapeutic landscape.
About NFJ Virtus Dividend Interest & Premium Strategy Fund of Beneficial Interest
Virtus Dividend, Interest & Premium Strategy Fund is a Massachusetts-based business trust. The primary investment objective of the company is to seek current income and gains, with a secondary objective of long-term capital appreciation. It pursues its investment objectives by investing in a diversified portfolio of dividend-paying common stocks and income-producing convertible securities.